Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models

Voprosy Virusologii

Volumn 55, Issue 3, 2010, Pages 19-27

  Lanava, I A ^a   Fadyakina, I T ^b   Eropkiri, M Yu ^b   Gudova, N V ^a   Romanovskaya, A A ^c   Danilenko, D M ^b   Vinogradova, S M ^a   Lepeshkin, A Yu ^a   Shestopalov, A M ^c  

^a Russian Chemical and Pharmaceutical Institute   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

Author keywords

Arbldol; Influenza viruses; Ingavirin; Mouse influenza pneumonia; Pandemic influenza A H1N1 virus; Ribavirin; Rimantadine; Virus inhibitory activity in cell culture

Indexed keywords

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZAVIRUS A; INFLUENZAVIRUS B; MURINAE; MUS; ORTHOMYXOVIRIDAE;

AMIDE; ANTIVIRUS AGENT; ARBIDOL; DICARBOXYLIC ACID; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; OSELTAMIVIR; PENTANEDIOIC ACID IMIDAZOLYL ETHANAMIDE; RIBAVIRIN; RIMANTADINE;

ANIMAL; ANTIVIRAL RESISTANCE; ARTICLE; CELL LINE; COMPARATIVE STUDY; DISEASE MODEL; DOG; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MOUSE; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; VIRUS PNEUMONIA; VIRUS REPLICATION;

ADMINISTRATION, ORAL; AMIDES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DICARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; IMIDAZOLES; INDOLES; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MICE; OSELTAMIVIR; PNEUMONIA, VIRAL; RIBAVIRIN; RIMANTADINE; VIRUS REPLICATION;

EID: 77954163490     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Assay Guidance Manual. http://www/ncgc.nih.gov/guidance/section2.html.
2. Boriskin Y., Leneva I., Pecheur E. et al. Arbidol: a broad-spec-trum antiviral compound that Woks viral fusion // Curr. Med. Chem. - 2008. - Vol. 15. - P. 997-1005.
3. Glushkov R. G. Arbidol. Antiviral, immunostimulant, interferon inducer // Drug of the Future. - 1992. - Vol. 17. - P. 1079-1081.
4. Hayden F. WHO guidelines on the use of vaccines and antivirals during influenza. - Annex 5-Considerations for the use of an-tivirals during an influenza pandemic, Geneva, 2-4 October, 2002.
5. Leneva I. A., Russell R. J., Boriskin Y. S. et al. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol // Antiviral Res. - 2009. - Vol. 81. - P. 132-140.
6. Monto A. Viral susceptibility and the choice of influenza antivirals // Clin. Infect. Dis. - 2008. - Vol. 47. - P. 346-348.
7. Shi L., Xiong H., He J. et al. Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, Coxsackie virus and adenovirus in vitro and in vivo // Arch. Virol. - 2007. - Vol. 152. - P. 1447.
8. Update: drug susceptibility of swine-origin influenza A(H1N1) viruses, April 2009. Centers for Disease Control and Prevention (CDC) // MMWR Morb Mortal Wkly Rep. 2009. - Vol. 58. - P. 433-435.
9. Wang M., Cat B., Li L. et al. Efficacy and safety of arbidol in treatment of naturally acquired influenza // Zhongguo Yi Xue Ke Xue Yuan Xue Bao. - 2004. - Vol. 26. - P. 289-293.
10. Watanabe W., Konno K., Ijichi K. et al. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents // J. Virol. Meth. - 1994. - Vol. 48, N 23. - P. 257-265.
11. Zlydnikov D. M., Kubar O. I., Kovaleva T. P. et al. Study of rimantadine in the USSR: a review of the literature // Rev. Infect. Dis. - 1981. - Vol. 3. - P. 408-421.